文献速递呼吸衰竭与机械通气消化、代谢与肾脏急症

包含辅助糖皮质激素的集束化干预对社区获得性肺炎住院患者结局的有效性:一项阶梯楔形随机临床试验

Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients With Community-Acquired Pneumonia: A Stepped-Wedge Randomized Clinical Trial.
PubMed 文献 · JAMA Intern Med · 2019-01-01
一句话结论在社区获得性肺炎住院患者中,包含泼尼松龙50 mg/d×7天、抗生素降阶梯、早期活动和营养筛查的集束化干预未显示有效性,且胃肠道出血发生率更高。

该研究为双盲阶梯楔形整群随机临床试验,在澳大利亚墨尔本2家三级医院普通内科病房连续纳入社区获得性肺炎住院患者,比较包含泼尼松龙醋酸酯50 mg/d×7天、标准化抗生素降阶梯、算法指导早期活动和营养不良筛查治疗的集束化干预与常规诊疗。意向性分析纳入816例患者(干预组401例,对照组415例),干预组与对照组住院时间几何均值比为0.95(95%CI 0.78-1.16),死亡和再入院无显著差异。干预组胃肠道出血比例高于对照组(9例[2.2%] vs 3例[0.7%]),未调整估计均值差为0.008(95%CI 0.005-0.010)。作者结论认为该集束化干预无有效性证据,且导致胃肠道出血发生率更高,临床试验中个体干预的有效性在联合实施时未必转化为实际效果,甚至可能造成净伤害。

要点

  • 在社区获得性肺炎住院患者中,包含泼尼松龙醋酸酯50 mg/d×7天的集束化干预与对照组住院时间几何均值比为0.95(95%CI 0.78-1.16),未达统计学显著。
  • 集束化干预组与对照组在死亡和再入院次要结局上无显著差异,调整性别和年龄后结果不变。
  • 干预组胃肠道出血9例(2.2%),对照组3例(0.7%),未调整估计均值差0.008(95%CI 0.005-0.010)。
  • 作者结论认为该集束化干预无有效性证据,且胃肠道出血发生率更高,临床试验中个体干预的有效性联合实施时未必转化为实际效果,甚至可能造成净伤害。

适用人群与场景

  • 在澳大利亚墨尔本2家三级医院普通内科病房连续纳入的社区获得性肺炎住院患者,共816例纳入意向性分析(干预组401例,对照组415例;女性351例,男性465例;平均[SD]年龄76[13]岁)。

处置流程与药物剂量

  • 治疗团队被建议在无任何禁忌证的情况下处方泼尼松龙醋酸酯50 mg/d,疗程7天。
  • 治疗团队被建议根据标准化标准将静脉抗生素降阶梯为口服抗生素。
  • 实施算法指导的早期活动和营养不良筛查与治疗。

研究设计与关键结果

  • 研究设计为双盲阶梯楔形整群随机临床试验,2016年8月1日至2017年10月29日在澳大利亚墨尔本2家三级医院普通内科病房开展,随访90天,连续纳入社区获得性肺炎住院患者,共筛查917例,816例纳入意向性分析。
  • 干预组与对照组住院时间(天)的未调整几何均值比为0.95(95%CI 0.78-1.16)。
  • 死亡和再入院次要结局无显著差异,进一步调整性别和年龄后结果不变。
  • 干预组胃肠道出血9例(2.2%),对照组3例(0.7%),未调整估计均值差为0.008(95%CI 0.005-0.010)。

证据类型、等级与局限

  • 证据类型:双盲阶梯楔形整群随机临床试验(ClinicalTrials.gov标识NCT02835040)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为该集束化干预无有效性证据,且导致胃肠道出血发生率更高;临床试验中个体干预的有效性在联合实施时未必转化为实际效果,甚至可能造成净伤害。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Community-acquired pneumonia remains a leading cause of hospitalization, mortality, and health care costs worldwide. Randomized clinical trials support the use of adjunctive corticosteroids, early progressive mobilization, antibiotic switching rules, and dietary interventions in improving outcomes. However, it is uncertain whether implementing these interventions will translate into effectiveness under routine health care conditions.

OBJECTIVE: To evaluate the effectiveness of a bundle of evidence-supported treatments under conditions of routine care in a representative population hospitalized for community-acquired pneumonia.

DESIGN, SETTING, AND PARTICIPANTS: A double-blind, stepped-wedge, cluster-randomized clinical trial with 90-day follow-up was conducted between August 1, 2016, and October 29, 2017, in the general internal medicine service at 2 tertiary hospitals in Melbourne, Australia, among a consecutive sample of patients with community-acquired pneumonia. The primary analysis and preparation of results took place between May 14 and November 25, 2018.

INTERVENTIONS: Treating clinical teams were advised to prescribe prednisolone acetate, 50 mg/d, for 7 days (in the absence of any contraindication) and de-escalate from parenteral to oral antibiotics according to standardized criteria. Algorithm-guided early mobilization and malnutrition screening and treatment were also implemented.

MAIN OUTCOMES AND MEASURES: Hospital length of stay, mortality, readmission, and intervention-associated adverse events (eg, gastrointestinal bleeding and hyperglycemia).

RESULTS: A total of 917 patients were screened, and 816 (351 women and 465 men; mean [SD] age, 76 [13] years) were included in the intention-to-treat analysis, with 401 patients receiving the intervention and 415 patients in the control group. An unadjusted geometric mean ratio of 0.95 (95% CI, 0.78-1.16) was observed for the difference in length of stay (days) between the intervention and control groups. Similarly, no significant differences were observed for the secondary outcomes of mortality and readmission, and the results remained unchanged after further adjustment for sex and age. The study reported higher proportions of gastrointestinal bleeding in the intervention group (9 [2.2%]) compared with the controls (3 [0.7%]), with an unadjusted estimated difference in mean proportions of 0.008 (95% CI, 0.005-0.010).

CONCLUSIONS AND RELEVANCE: This bundled intervention including adjunctive corticosteroids demonstrated no evidence of effectiveness and resulted in a higher incidence of gastrointestinal bleeding. Efficacy of individual interventions demonstrated in clinical trials may not necessarily translate into effectiveness when implemented in combination and may even result in net harm.

TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02835040.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Lloyd M, Karahalios A, Janus E, et al. Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients With Community-Acquired Pneumonia: A Stepped-Wedge Randomized Clinical Trial. JAMA Intern Med. 2019. PMID: 31282921. doi:10.1001/jamainternmed.2019.1438

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。